Tech Company Financing Transactions
Bright Peak Therapeutics Funding Round
On 7/30/2020, Bright Peak Therapeutics announced $35 million in funding from Versant Ventures.
Transaction Overview
Company Name
Announced On
7/30/2020
Transaction Type
Venture Equity
Amount
$35,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The series A capital from Versant will fuel part of that journey, but Bright Peak plans to supplement that with pharma partnerships and additional investors.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Aeschenvorstadt 36
Basel, 4051
Switzerland
Basel, 4051
Switzerland
Phone
Undisclosed
Email Address
Not Recorded
Overview
Bright Peak is developing next-generation engineered cytokines for immuno-oncology indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sef Kurstjens
Browse more venture capital transactions:
Prev: 7/30/2020: Thrive Earlier Detection venture capital transaction
Next: 7/31/2020: VodaSafe venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs